Suppr超能文献

神经激肽 1 受体拮抗剂,ezlopitant,可减少蔗糖和乙醇的食欲反应。

The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol.

机构信息

Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America.

出版信息

PLoS One. 2010 Sep 1;5(9):e12527. doi: 10.1371/journal.pone.0012527.

Abstract

BACKGROUND

The current obesity epidemic is thought to be partly driven by over-consumption of sugar-sweetened diets and soft drinks. Loss-of-control over eating and addiction to drugs of abuse share overlapping brain mechanisms including changes in motivational drive, such that stimuli that are often no longer 'liked' are still intensely 'wanted' [7], . The neurokinin 1 (NK1) receptor system has been implicated in both learned appetitive behaviors and addiction to alcohol and opioids; however, its role in natural reward seeking remains unknown.

METHODOLOGY/PRINCIPAL FINDINGS: We sought to determine whether the NK1-receptor system plays a role in the reinforcing properties of sucrose using a novel selective and clinically safe NK1-receptor antagonist, ezlopitant (CJ-11,974), in three animal models of sucrose consumption and seeking. Furthermore, we compared the effect of ezlopitant on ethanol consumption and seeking in rodents. The NK1-receptor antagonist, ezlopitant decreased appetitive responding for sucrose more potently than for ethanol using an operant self-administration protocol without affecting general locomotor activity. To further evaluate the selectivity of the NK1-receptor antagonist in decreasing consumption of sweetened solutions, we compared the effects of ezlopitant on water, saccharin-, and sodium chloride (NaCl) solution consumption. Ezlopitant decreased intake of saccharin but had no effect on water or salty solution consumption.

CONCLUSIONS/SIGNIFICANCE: The present study indicates that the NK1-receptor may be a part of a common pathway regulating the self-administration, motivational and reinforcing aspects of sweetened solutions, regardless of caloric value, and those of substances of abuse. Additionally, these results indicate that the NK1-receptor system may serve as a therapeutic target for obesity induced by over-consumption of natural reinforcers.

摘要

背景

当前的肥胖流行被认为部分是由于过度摄入含糖饮食和软饮料所致。对食物的失控性摄入和对滥用药物的成瘾具有重叠的大脑机制,包括动机驱动力的变化,例如,通常不再“喜欢”的刺激物仍然会被强烈地“想要”[7]。神经激肽 1(NK1)受体系统与习得性摄食行为以及对酒精和阿片类药物的成瘾有关;然而,其在天然奖赏寻求中的作用仍不清楚。

方法/主要发现:我们试图确定 NK1 受体系统是否在蔗糖的强化特性中起作用,使用新型选择性和临床安全的 NK1 受体拮抗剂 ezlopitant(CJ-11,974),在三种蔗糖消耗和寻求的动物模型中进行了研究。此外,我们比较了 ezlopitant 对乙醇消耗和寻求的影响。使用操作性自我给药方案,NK1 受体拮抗剂 ezlopitant 比乙醇更有效地降低了蔗糖的食欲反应,而不影响一般的运动活动。为了进一步评估 NK1 受体拮抗剂降低甜味溶液消耗的选择性,我们比较了 ezlopitant 对水、糖精和氯化钠(NaCl)溶液消耗的影响。Ezlopitant 减少了糖精的摄入,但对水或咸溶液的摄入没有影响。

结论/意义:本研究表明,NK1 受体可能是调节甜味溶液的自我给药、动机和强化方面的共同途径的一部分,而与热量值无关,也与滥用物质的自我给药、动机和强化方面有关。此外,这些结果表明,NK1 受体系统可能成为因过度摄入天然强化物而导致肥胖的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83fa/2931709/73bc0d546ef5/pone.0012527.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验